Study Links Viagra Use to Potential Hearing Impairment

Topic: Deafness and Hearing Loss
Author: University of Alabama at Birmingham
Published: 2010/05/18 - Updated: 2024/10/01
Publication Type: Research, Study, Analysis - Peer-Reviewed: Yes
Contents: Summary - Introduction - Main Item - Related Topics

Synopsis: Research by University of Alabama shows an association between hearing loss and use of erectile dysfunction drug Viagra. This is the first epidemiologic study to evaluate the relationship between PDE-5i drugs and long-term hearing loss. Men who reported use of PDE-5i medications were twice as likely to also report hearing loss as were men who had not used the drugs.

Why it matters: This study is significant because it highlights an important potential side effect of Viagra (sildenafil) that users and healthcare providers should be aware of. It discusses the U.S. Food and Drug Administration's (FDA) decision to require labeling changes for erectile dysfunction drugs, specifically warning about the risk of sudden hearing loss. This information is crucial for patient safety and informed decision-making, as it alerts both consumers and medical professionals to monitor for this rare but serious adverse effect. The article's relevance extends beyond just Viagra users, as it also applies to other PDE5 inhibitors like Cialis and Levitra - Disabled World.

Introduction

Findings published in Archives of Otolaryngology-Head and Neck Surgery indicate a potential for long-term hearing loss following use of Viagra, and possibly following use of other phosphodiesterase type 5 inhibitors (PDE-5i) drugs such as Cialis and Levitra, although results on those drugs are inconclusive.

Main Item

"It appears from these findings that the current government warning regarding hearing loss and the use of PDE-5i medications is warranted," said study author Gerald McGwin, Ph.D., a professor of epidemiology in the UAB School of Public Health. "Though there are limitations to this study, it is prudent that patients using these medications be warned about the signs and symptoms of hearing impairment and be encouraged to seek immediate medical attention to potentially forestall permanent damage."

In 2007, following the report of several case studies potentially linking PDE-5i use and sudden hearing loss, the Food and Drug Administration announced labeling changes for PDE-5i medications so that the risk of hearing problems was more prominently displayed. McGwin said this is the first epidemiologic study to evaluate the relationship between PDE-5i drugs and long-term hearing loss.

McGwin examined data on 11,525 men over 40 years of age gathered by the Medical Expenditure Panel Survey, a survey conducted by the federal Agency for Healthcare Research and Quality between 2003 and 2006. Men who reported use of PDE-5i medications were twice as likely to also report hearing loss as were men who had not used the drugs.

McGwin said the relationship was strongest for men reporting use of Sildenafil (Viagra) over those who used tadalafil (Cialis) or vardenafil (Levitra), a finding he attributed in part to a small sample size for both of the latter drugs. McGwin said the findings indicated an elevated but not statistically significant increase in hearing loss for users of tadalafil and vardenafil.

PDE-5i drugs were originally designed to treat pulmonary hypertension and are now used extensively in the treatment of erectile dysfunction (ED). McGwin said one important consideration in evaluating the nature of the relationship between the drugs and hearing is the existence of a plausible biological mechanism of how these drugs might cause hearing loss.

"PDE-5i medications work in ED patients by their ability to increase blood flow to certain tissues in the body," said McGwin. "It has been hypothesized that they may have a similar effect on similar tissues in the ear, where an increase of blood flow could potentially cause damage leading to hearing loss."

McGwin acknowledged limitations in the study, including the limited sample size for tadalafil and vardenafil, concerns over under-reporting of use of PDE-5i medications and confounding factors such as pre-existing conditions that might also contribute to hearing loss. He suggested that additional research regarding the risk from PDE-5i is necessary due to the largely irreversible nature of hearing loss and its impact on quality of life.

"The results of the current study in conjunction with a plausible biologic mechanism lend support to the FDA's decision to warn patients about the potential risk posed by PDE-5i use," he said.

Attribution/Source(s):

This peer reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by University of Alabama at Birmingham, and published on 2010/05/18 (Edit Update: 2024/10/01), the content may have been edited for style, clarity, or brevity. For further details or clarifications, University of Alabama at Birmingham can be contacted at uab.edu/home/. NOTE: Disabled World does not provide any warranties or endorsements related to this article.

Explore Related Topics

1 - - DC signal polarity changes from positive to negative when the cochlea has been exposed to harmful noise and this signal can provide an indication of ear health status.

2 - - Researchers propose a method for sound localization based on frequency modulation of the received signal in individuals possessing monoaural hearing.

3 - - Research shows hope for hearing loss as scientists develop method to repair damaged structures deep inside the human ear.

4 - - Research from Oregon State University shows for adults who acquire severe hearing loss, accepting and adapting play key roles in sustaining a career and thriving in the workplace.

5 - - People who can not hear people clearly in a noisy environment, but pass a hearing test at the doctor, may have hidden hearing loss.

Complete List of Related Information

Page Information, Citing and Disclaimer

Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): University of Alabama at Birmingham. (2010, May 18 - Last revised: 2024, October 1). Study Links Viagra Use to Potential Hearing Impairment. Disabled World. Retrieved October 13, 2024 from www.disabled-world.com/disability/types/hearing/hearing-viagra.php

Permalink: <a href="https://www.disabled-world.com/disability/types/hearing/hearing-viagra.php">Study Links Viagra Use to Potential Hearing Impairment</a>: Research by University of Alabama shows an association between hearing loss and use of erectile dysfunction drug Viagra.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.